Show
Sort by
-
Assessment of therapy response by DCE-MRI with a macromolecular gadolinium contrast agent.
-
Squamous cell carcinoma of the anus: a possible target for EGFR inhibition?
-
Management and treatment of chronic hepatitis B virus: Belgian Association for the Study of the Liver (BASL) 2007 guidelines
-
Cystic fibrosis presenting as diabetes insipidus unresponsive to desmopressin
-
Hypocalcaemic seizures: sign of intestinal disease?
-
Is combined F-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography superior to Positron Emission Tomography or Computed Tomography alone for diagnosis, staging and restaging of pancreatic lesions ?
-
Immunogenicity of infliximab: how to handle the problem ?
-
A health economic model to assess the cost-effectiveness of pegylated interferon alpha-2a and ribavirin in patients with moderate chronic hepatitis C and persistently normal alanine aminotransferase levels
-
Treatment of small bowel subocclusive Crohn's disease with infliximab: an open pilot study
-
Capsule Endoscopy in paediatrics: multicentric Belgian study